γ-oryzanol enhances adipocyte differentiation and glucose uptake

Nutrients

Volumn 7, Issue 6, 2015, Pages 4851-4861

  Jung, Chang Hwa ^a,b   Lee, Da Hye ^a   Ahn, Jiyun ^a,b   Lee, Hyunjung ^b   Choi, Won Hee ^a   Jang, Young Jin ^b   Ha, Tae Youl ^a,b  

^a University of Science and Technology (UST)   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

3T3 L1; Adipocyte; Glucose uptake; MTORC1; PPAR ; oryzanol

Indexed keywords

BIOLOGICAL MARKER; CCAAT ENHANCER BINDING PROTEIN ALPHA; FERULIC ACID; GAMMA ORYZANOL; GLUCOSE TRANSPORTER 4; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHYTOSTEROL; S6 KINASE; TRITERPENE DERIVATIVE; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; GAMMA-ORYZANOL; GLUCOSE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; PHENYLPROPIONIC ACID DERIVATIVE; PLANT MEDICINAL PRODUCT; RPS6KA1 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DIABETIC OBESITY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPE; GENE TRANSLOCATION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; IMMUNOBLOTTING; INSULIN SENSITIVITY; LIPID STORAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INSULIN RESISTANCE; METABOLISM; ORYZA; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WHOLE GRAIN;

MAMMALIA;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; MICE; MULTIPROTEIN COMPLEXES; ORYZA; PHENYLPROPIONATES; PHOSPHORYLATION; PHYTOCHEMICALS; PPAR GAMMA; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; WHOLE GRAINS;

EID: 84934992017     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064851     Document Type: Article

References (31)

1. Tamori, Y.; Masugi, J.; Nishino, N.; Kasuga, M. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes 2002, 51, 2045–2055.
2. Wang, L.; Waltenberger, B.; Pferschy-Wenzig, E.M.; Blunder, M.; Liu, X.; Malainer, C.; Blazevic, T.; Schwaiger, S.; Rollinger, J.M.; Heiss, E.H. et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): A review. Biochem. Pharmacol. 2014, 92, 73–89.
3. Rosen, E.D.; Spiegelman, B.M. PPARgamma: A nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 2001, 276, 37731–37734.
4. Chawla, A.; Lazar, M.A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. USA 1994, 91, 1786–1790.
5. Sugii, S.; Olson, P.; Sears, D.D.; Saberi, M.; Atkins, A.R.; Barish, G.D.; Hong, S.H.; Castro, G.L.; Yin, Y.Q.; Nelson, M.C. et al. PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc. Natl. Acad. Sci. USA 2009, 106, 22504–22509.
6. Maeda, N.; Takahashi, M.; Funahashi, T.; Kihara, S.; Nishizawa, H.; Kishida, K.; Nagaretani, H.; Matsuda, M.; Komuro, R.; Ouchi, N. et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50, 2094–2099.
7. Moyers, J.S.; Shiyanova, T.L.; Mehrbod, F.; Dunbar, J.D.; Noblitt, T.W.; Otto, K.A.; Reifel-Miller, A.; Kharitonenkov, A. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J. Cell. Physiol. 2007, 210, 1–6.
8. Sugano, M.; Koba, K.; Tsuji, E. Health benefits of rice bran oil. Anticancer Res. 1999, 19, 3651–3657.
9. Goufo, P.; Trindade, H. Rice antioxidants: Phenolic acids, flavonoids, anthocyanins, proanthocyanidins, tocopherols, tocotrienols, gamma-oryzanol, and phytic acid. Food Sci. Nutr. 2014, 2, 75–104.
10. Islam, M.S.; Murata, T.; Fujisawa, M.; Nagasaka, R.; Ushio, H.; Bari, A.M.; Hori, M.; Ozaki, H. Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br. J. Pharmacol. 2008, 154, 812–824.
11. Islam, M.S.; Nagasaka, R.; Ohara, K.; Hosoya, T.; Ozaki, H.; Ushio, H.; Hori, M. Biological abilities of rice bran-derived antioxidant phytochemicals for medical therapy. Curr. Top. Med. Chem. 2011, 11, 1847–1853.
12. Panlasigui, L.N.; Thompson, L.U. Blood glucose lowering effects of brown rice in normal and diabetic subjects. Int. J. Food Sci. Nutr. 2006, 57, 151–158.
13. Aune, D.; Norat, T.; Romundstad, P.; Vatten, L.J. Whole grain and refined grain consumption and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Eur. J. Epidemiol. 2013, 28, 845–858.
14. Ye, E.Q.; Chacko, S.A.; Chou, E.L.; Kugizaki, M.; Liu, S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J. Nutr. 2012, 142, 1304–1313.
15. Mohan, V.; Spiegelman, D.; Sudha, V.; Gayathri, R.; Hong, B.; Praseena, K.; Anjana, R.M.; Wedick, N.M.; Arumugam, K.; Malik, V. et al. Effect of brown rice, white rice, and brown rice with legumes on blood glucose and insulin responses in overweight Asian Indians: A randomized controlled trial. Diabetes Technol. Ther. 2014, 16, 317–325.
16. Kozuka, C.; Sunagawa, S.; Ueda, R.; Higa, M.; Tanaka, H.; Shimizu-Okabe, C.; Ishiuchi, S.; Takayama, C.; Matsushita, M.; Tsutsui, M. et al. Gamma-oryzanol protects pancreatic beta-cells against endoplasmic reticulum stress in male mice. Endocrinology 2015, 156, 1242–1250.
17. Kozuka, C.; Yabiku, K.; Takayama, C.; Matsushita, M.; Shimabukuro, M. Natural food science based novel approach toward prevention and treatment of obesity and type 2 diabetes: Recent studies on brown rice and gamma-oryzanol. Obes. Res. Clin. Pract. 2013, 7, e165–e172.
18. Wang, Q.; Khayat, Z.; Kishi, K.; Ebina, Y.; Klip, A. GLUT4 translocation by insulin in intact muscle cells: Detection by a fast and quantitative assay. FEBS Lett. 1998, 427, 193–197.
19. Reynoso, R.; Salgado, L.M.; Calderon, V. High levels of palmitic acid lead to insulin resistance due to changes in the level of phosphorylation of the insulin receptor and insulin receptor substrate-1. Mol. Cell. Biochem. 2003, 246, 155–162.
20. Lamming, D.W.; Sabatini, D.M. A central role for mTOR in lipid homeostasis. Cell Metab. 2013, 18, 465–469.
21. Shimabukuro, M.; Higa, M.; Kinjo, R.; Yamakawa, K.; Tanaka, H.; Kozuka, C.; Yabiku, K.; Taira, S.; Sata, M.; Masuzaki, H. Effects of the brown rice diet on visceral obesity and endothelial function: The BRAVO study. Br. J. Nutr. 2014, 111, 310–320.
22. Kozuka, C.; Yabiku, K.; Sunagawa, S.; Ueda, R.; Taira, S.; Ohshiro, H.; Ikema, T.; Yamakawa, K.; Higa, M.; Tanaka, H. et al. Brown rice and its component, gamma-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice. Diabetes 2012, 61, 3084–3093.
23. Imam, M.U.; Ismail, M.; Ithnin, H.; Tubesha, Z.; Omar, A.R. Effects of germinated brown rice and its bioactive compounds on the expression of the peroxisome proliferator-activated receptor gamma gene. Nutrients 2013, 5, 468–477.
24. Bryant, N.J.; Govers, R.; James, D.E. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002, 3, 267–277.
25. Son, M.J.; Rico, C.W.; Nam, S.H.; Kang, M.Y. Effect of oryzanol and ferulic acid on the glucose metabolism of mice fed with a high-fat diet. J. Food Sci. 2011, 76, H7–H10.
26. Rondinone, C.M.; Wang, L.M.; Lonnroth, P.; Wesslau, C.; Pierce, J.H.; Smith, U. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 1997, 94, 4171–4175.
27. Shen, K.P.; Hao, C.L.; Yen, H.W.; Chen, C.Y.; Wu, B.N.; Lin, H.L. Pre-germinated brown rice prevents high-fat diet induced hyperglycemia through elevated insulin secretion and glucose metabolism pathway in C57BL/6J strain mice. J. Clin. Biochem. Nutr. 2015, 56, 28–34.
28. Buller, C.L.; Loberg, R.D.; Fan, M.H.; Zhu, Q.; Park, J.L.; Vesely, E.; Inoki, K.; Guan, K.L.; Brosius, F.C., 3rd. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am. J. Physiol. Cell Physiol. 2008, 295, C836–C843.
29. Hamada, S.; Hara, K.; Hamada, T.; Yasuda, H.; Moriyama, H.; Nakayama, R.; Nagata, M.; Yokono, K. Upregulation of the mammalian target of rapamycin complex 1 pathway by Ras homolog enriched in brain in pancreatic beta-cells leads to increased beta-cell mass and prevention of hyperglycemia. Diabetes 2009, 58, 1321–1332.
30. Pende, M.; Kozma, S.C.; Jaquet, M.; Oorschot, V.; Burcelin, R.; le Marchand-Brustel, Y.; Klumperman, J.; Thorens, B.; Thomas, G. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 2000, 408, 994–997.
31. Chong, Z.Z.; Maiese, K. Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc. Diabetol. 2012, 11, 45, doi:10.1186/1475-2840-11-45.